Aptamer Group

1. 20 Aug 26
   Appointment of Joint Corporate Broker

   Aptamer Group plc (AIM: APTA), the developer of next-generation synthetic Optimer® binders, is pleased to announce the appointment of Cavendish Capital Markets Limited ("Cavendish") as Joint Corporate Broker to the Company with immediate effect.

   RNS 9730805 ↗
2. 14 Aug 26
   Director Fee Shares and Grant of Options

   Aptamer Group plc (AIM: APTA), the developer of next-generation synthetic Optimer® binders, today announces that it has issued 12,936,511 new ordinary shares as payment for Non-Executive services and, in line with the Company's RNS announcement of 25 March...

   RNS 9721550 ↗
3. 13 Jul 26
   Trading Update

   Aptamer Group plc (AIM: APTA), the developer of next-generation synthetic Optimer® binders, today provides a trading update for the year ended 30 June 2026 ("FY2026").

   RNS 9664198 ↗
4. 08 Jul 26
   Aptamer initiates Ebola diagnostic test programme

   New programme to develop rapid diagnostic test for rare Bundibugyo Ebola strain during largest outbreak on record

   RNS 9657173 ↗
5. 25 Jun 26
   Programme and technical development update

   First AI-generated Optimer® candidates delivered for laboratory testing

   RNS 9635383 ↗
6. 08 Jun 26
   Rapid testing programme for fortified foods

   Aptamer initiates rapid testing programme for fortified foods

   RNS 9605327 ↗
7. 31 Mar 26
   Result of Retail Offer and Posting of Notice of GM

   £4.5 million raised pursuant to the Placing, Subscription and the Retail Offer

   RNS 9499136 ↗
8. 26 Mar 26
   Retail Offer to raise up to £0.5 million

   Retail Offer to raise up to £0.5 million

   RNS 9492833 ↗
9. 26 Mar 26
   Results of Placing

   Aptamer Group plc (AIM: APTA), the leading developer of next-generation synthetic binders delivering innovation to the life science industry, announces that is has successfully raised gross proceeds of £4.275 million before expenses through a placing of...

   RNS 9492543 ↗
10. 25 Mar 26
    Interim Results and Notice of Investor Webinar

    Interim results for the six months ended 31 December 2025

    RNS 9490472 ↗
11. 25 Mar 26
    Proposed Placing, Subscription and Retail Offer

    Aptamer Group plc (AIM: APTA), the leading developer of next-generation synthetic binders delivering innovation to the life science industry, announces its intention to conduct an equity Fundraise to raise gross proceeds of an expected minimum of £3.75 million.

    RNS 9490313 ↗
12. 18 Mar 26
    Launch of targeted radiopharmaceutical programme

    Three therapeutic targets selected across high‑value clinical indications

    RNS 9479205 ↗
13. 17 Feb 26
    Technical Feasibility for Pathogen Detector

    Aptamer Group plc (AIM: APTA), the developer of next-generation synthetic binders for the life sciences industry, is pleased to announce the successful completion of Phase 1 of its collaboration with Metir plc ("Metir") (AIM: MET), achieving the agreed...

    RNS 9433559 ↗
14. 11 Feb 26
    Optimer® Technology in Launched Library Prep Kit

    Optimer® Technology in Newly Launched Library Prep Kit

    RNS 9424683 ↗
15. 29 Jan 26
    Contract wins and first cash licensing receipts

    Further repeat contract wins and first cash licensing receipts

    RNS 9392577 ↗
16. 07 Jan 26
    Trading update - Media comment and speculation

    Aptamer Group plc (AIM: APTA), the developer of next-generation synthetic binders for the life sciences industry, provides an update regarding media comment and speculation following the trading update released by the Company earlier today.

    RNS 9339510 ↗
17. 07 Jan 26
    Half Year Trading Update

    Revenue up 27% to £0.83 million with an FY26 fee-for-service order book of over £2.0 million

    RNS 9337507 ↗
18. 23 Dec 25
    Aptamer signs licensing agreement with Alphazyme

    Royalty payments on product sales plus milestone and manufacturing revenues

    RNS 9314211 ↗
19. 16 Dec 25
    Licensing agreement with Twist Bioscience

    Non-exclusive license for Optimer® binder targeting the next-generation sequencing market

    RNS 9300060 ↗
20. 27 Nov 25
    Result of AGM

    Aptamer Group plc (AIM: APTA), the leading developer of next-generation synthetic binders delivering innovation to the life science industry, today announces that the results of voting on the resolutions put to shareholders at its Annual General Meeting...

    RNS 9261731 ↗
21. 27 Nov 25
    AGM Statement

    Aptamer Group plc (AIM: APTA), the leading developer of next-generation synthetic binders delivering innovation to the life science industry, will hold its Annual General Meeting (AGM) at 11:00 am today at the offices of Aptamer Group, Windmill House,...

    RNS 9259958 ↗
22. 14 Nov 25
    Strong contract wins build commercial momentum

    Strong contract wins continue to build commercial momentum

    RNS 9232976 ↗
23. 04 Nov 25
    New contract with top five pharma company

    Aptamer secures major repeat business with top 5 pharmaceutical partner

    RNS 9210166 ↗
24. 14 Oct 25
    Final Results

    Full year results for the twelve months ended 30 June 2025

    RNS 9168684 ↗
25. 13 Oct 25
    New contract with top 10 pharma

    £112,000 contract builds revenue visibility and reinforces Optimer® momentum

    RNS 9166000 ↗
26. 08 Oct 25
    Major top 3 global pharma contract win

    £665,000 of additional contract value in recently signed agreements, £315,000 of smaller deals

    RNS 9156906 ↗

Source: Investegate RNS archive. Quotes are short extracts. Not investment advice.